HeartBeam, Inc. BEAT 深 沪
等待开盘 12-19 09:30:00 美东时间
2.71
-0.360
-11.73%
华盛通- 最 高3.24
- 今 开2.95
- 成交量 1020.96万股
- 最 低 2.50
- 昨 收 3.07
- 总市值 9162.43万
- 52周最高 4.00
- 市盈率 静 --
- 换手率 30.20%
- 52周最低 0.54
- 委 比 -52.91%
- 总股本 3380.97万
- 历史最高 71.96
- 量 比 0.15
- 振 幅 24.10%
- 历史最低 0.54
- 每 手 1
- 风险率 0.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation
Austin, Texas, United States, December 18th, 2025, FinanceWire HeartBeam (NASDA...
今天 02:00
Why Aditxt Shares Are Trading Higher By Around 63%; Here Are 20 Stocks Moving Premarket
Shares of Aditxt Inc (NASDAQ:ADTX) rose sharply in pre-market trading following...
12-17 17:35
美股牛股 | B Riley金融大涨超53%，补交逾期第二季度报告，该季度实现扭亏为盈；Rezolve涨28%
B Riley金融大涨超53%，补交逾期第二季度报告，该季度实现扭亏为盈；Rezolve涨28%，预计年度经常性收入突破2亿美元，大幅超越此前目标>>
12-17 18:50
3 Penny Stocks to Watch Now, 12/16/25
cbdMD, iRobot, and HeartBeam are the 3Penny Stocksto watch on Decem...
12-16 23:29
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
12-12 10:24
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
12-11 10:33
Why Is Micro Cap HeartBeam Stock Surging On Wednesday?
HeartBeam shares rise after FDA clears its 12-lead ECG software, boosting plans for a 2026 launch and expanded cardiac detection technology.
12-11 00:27
Why Is HeartBeam Stock (BEAT) Up Today?
HeartBeam stock gained alongside approval from the FDA for a heart monitoring d...
12-10 21:08
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
HC Wainwright & Co. Initiates Coverage On HeartBeam with Buy Rating, Announces Price Target of $2.5
HC Wainwright & Co. analyst Yi Chen initiates coverage on HeartBeam (NASDAQ:BEAT) with a Buy rating and announces Price Target of $2.5.
12-08 20:25
